Citation Impact
Citing Papers
Cell Death: The Significance of Apoptosis
1980 Standout
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Protracted Intra Arterial Chemotherapy with Sequential Courses of Antimitotics and Radiotherapy in the Treatment of Extended Head and Neck Cancer
1968
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
2005 StandoutNobel
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989
Self-Assembling Drugs: A New Approach to Biochemical Modulation in Cancer Chemotherapy
1994
Adverse Health Effects of Marijuana Use
2014 Standout
Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium
1988
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
1988
The biology and management of non-small cell lung cancer
2018 StandoutNature
Hematopoietic Growth Factors
1989
Drug penetration in solid tumours
2006 Standout
Choosing anticancer drug targets in the postgenomic era
1999 StandoutNobel
The colony stimulating factors discovery, development, and clinical applications
1990
Head and neck cancer
2008 Standout
Metabolism and action of amino acid analog anti-cancer agents
1990
Identification and characterization of an inhibitor of haemopoietic stem cell proliferation
1990 Nature
Measurement of chemoresistance markers in patients with stage iii non–small cell lung cancer: a novel approach for patient selection
2003
The Hallmarks of Cancer
2000 Standout
Adjuvant 5-Fluorouracil and Leucovorin With or Without Interferon Alfa-2a in Colon Carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol C-05
1998
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
1992
Someone to live for: social well-being, parenthood status, and decision-making in oncology.
1995
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
2000 Standout
Cisplatin and DNA repair in cancer chemotherapy
1995
3 The Medicinal Chemistry of the Azido Group
1994
Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia
1990
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
DNA Repair: Enzymatic Mechanisms and Relevance to Drug Response
1996
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines
1993
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
1997 Standout
Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors
1998
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.
1989
Measuring response in a post-RECIST world: from black and white to shades of grey
2006
CED-1 Is a Transmembrane Receptor that Mediates Cell Corpse Engulfment in C. elegans
2001 StandoutNobel
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
1995
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Clinical Pharmacology of 5-Fluorouracil
1989 Standout
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
1993 Standout
Epoetin alfa improves quality of life in patients with cancer
2004
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor.
1992
Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
2011
Mechanisms of resistance to cisplatin
2001
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Cancer of the Ovary
2004 Standout
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP
1975
Radionuclide Localization of Intraarterial Infusions in Head and Neck Cancer1
1984
Blood Cell Separation in the Dog by Continuous Flow Centrifugation
1968
Adriamycin
1974 Standout
Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia
1986
The impact of induction anthracycline on long‐term failure‐free survival in childhood acute lymphoblastic leukemia
1986
Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results.
1978
Phase II evaluation of adriamycin in human neoplasia
1973
Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia
1984
Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
1966 Standout
Dose response evaluation of adriamycin in human neoplasia
1977
Normal Granulocyte Transfusion Therapy
1972
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy
1978
Different drugs arrest cells at a number of distinct stages in G2
1975 Nature
Regression Models and Life-Tables
1972 Standout
The cardiotoxicity of adriamycin and daunomycin in children
1976
Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological Fluids
1978
Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection
1979
Immunoadsorption for Removal of a and B Blood-Group Antibodies
1981 StandoutNobel
Topical Instillation of Doxorubicin Hydrochloride in the Treatment of Recurring Superficial Transitional Cell Carcinoma of the Bladder
1977
Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study
1976
Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.
1987
Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update
1983
Acquired multicellular-mediated resistance to alkylating agents in cancer.
1993
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Requirement of Mip-1α for an Inflammatory Response to Viral Infection
1995 StandoutScienceNobel
Bone-Marrow Transplantation
1975 Standout
Treatment of Chronic Lymphocytic Leukemia by Extracorporeal Irradiation
1968 StandoutNobel
Drug Treatment of Breast Cancer
1978
Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.
1996 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Advances in the Treatment of Acute Myelogenous Leukemia
1979
The RAD9 Gene Controls the Cell Cycle Response to DNA Damage in Saccharomyces cerevisiae
1988 StandoutScienceNobel
Human Leukemic Cells: In vitro Growth of Colonies Containing the Philadelphia (Ph 1 ) Chromosome
1971 Science
Protective Environment for Marrow Transplant Recipients
1978
Factors related to length of complete remission in adult acute leukemia
1980
The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma
1978
Prediction of Response to Cancer Chemotherapy
1983
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Single-agent and combination-drug regional chemotherapy for head and neck cancer using an implantable infusion pump
1984
Chemotherapy of Thyroid Cancer with Adriamycin
1974
Reporting results of cancer treatment
1981 Standout
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
2002
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Aplastic Anemia
1982 StandoutNobel
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage
1977
Adriamycin: A proposal on the specificity of drug action
1978
Surgical Aspects of Intra‐Arterial Chemotherapy of Outpatients with Head and Neck Cancer
1985
A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.
1979
Bone Marrow Transplantation or Chemotherapy After Remission Induction for Adults with Acute Nonlymphoblastic Leukemia
1984
Signal Sequence Trap: a Cloning Strategy for Secreted Proteins and Type I Membrane Proteins
1993 StandoutScienceNobel
Hematopoietic cytokines
2008
High dose cytosine arabinoside (HDARAC) in refractory acute leukemia
1979
Clinical trial of intra-arterial polychemotherapy in the treatment of carcinoma of the oral cavity
1978
A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial
1984
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
1979 StandoutNobel
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)
1979
A clinicopathologic analysis of adriamycin cardiotoxicity
1973 Standout
Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia
1984
Mitochondria and Apoptosis
1998 StandoutScience
Allogeneic Marrow Engraftment by Cross Circulation in Lethally Irradiated Dogs
1966 StandoutNobel
A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship
1970
Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.
2003
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer
1992
Treatment of advanced Hodgkin's disease with B-CAVe following MOPP failure
1978
High-dose cytosine arabinoside therapy for refractory leukemia
1983
Circulating Immune Complexes and the Prognosis of Acute Myeloid Leukemia
1982
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Neural Computing in Cancer Drug Development: Predicting Mechanism of Action
1992 StandoutScienceNobel
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
1983
Factors Affecting Mortality of Gram-Negative Rod Bacteremia
1971
The Anthracycline Antineoplastic Drugs
1981 Standout
Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin
1977
Identical Twins and Chronic Myelocytic Leukemia
1965
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
1994
Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study
1982
Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule
1974
Apoptosis in AIDS
1993 StandoutScienceNobel
Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer.
1986
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.
1984
Reactivity of a monoclonal antibody with human ovarian carcinoma.
1981
Clonal origin of human tumors
1976
Adriamycin and metabolites: Separation by high-pressure liquid chromatography and quantitation by radioimmunoassay
1975
Gram-Negative Bacteremia
1962 Standout
The Medical Course of Cancer Patients With Fever and Neutropenia
1988
Chemotherapy of advanced soft-tissue sarcomas in adults
1977
Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia
1983
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Granulocyte Transfusions for the Prevention of Infection in Patients Receiving Bone-Marrow Transplants
1978 StandoutNobel
Hematopoietic Graft Detected by a Change in ABO Group
1964
Chromosomal mosaicism associated with prolonged remission in chronic myelogenous leukemia
1976
Works of Emil Frei being referenced
Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.
1978
Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate.
1976
Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.
1975
A comparative study of optimal medical care with and without azaserine in multiple myeloma
1961
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
1993
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo
1990 Science
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
1990
Gene deletion: a new target for cancer chemotherapy
1993
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.
1988
High-dose ifosfamide with mesna uroprotection: a phase I study.
1990
Bone marrow autotransplantation for solid tumors--prospects.
1989
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression
1988
Clinical Studies with Vincristine
1963
THE EFFECT OF SKIN HOMOGRAFT REJECTION ON RECIPIENT AND DONOR MIXED LEUKOCYTE CULTURES
1965
Clinical studies of fever and infection in cancer
1960
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.
1986
Combination cancer therapy: Presidential address.
1972
Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma
1971
The Treatment of Acute Myelogenous Leukemia in Children and Adults: VAPA Update
1983
Dose: A critical factor in cancer chemotherapy
1980
Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
1987
VAPA10: A Treatment Program for Acute Myelocytic Leukemia
1981
Development of an effective treatment program for childhood acute lymphocytic leukemia: A preliminary report
1976
Phase I trial of combination therapy with PALA and 5-FU.
1981
The Distribution of the Philadelphia Chromosome in Patients with Chronic Myelogenous Leukemia
1963
Prognostic significance of pretreatment proliferative activity in adult acute leukemia
1977
Pseudomonas septicemia
1958
Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo.
1970
The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy
1963
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
1975
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide
1972
QUANTITATIVE STUDIES OF HUMAN LEUKOCYTIC AND FEBRILE RESPONSE TO SINGLE AND REPEATED DOSES OF PURIFIED BACTERIAL ENDOTOXIN*
1962
THE STATHMOKINETIC EFFECT OF VINCRISTIME.
1964
Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide.
1968
Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
1975
Studies of patients in a laminar air flow unit
1969
Alkylating agent resistance: in vitro studies with human cell lines.
1985
Clinical trials with adriamycin
1971
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia
1971
Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): Addition of an anthracycline to vincristine and prednisone
1977
Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
1960
The chemotherapy of human and animal acute leukemia.
1971
Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosine
1971
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
1972
The Philadelphia Chromosome and Chronic Myelogenous Leukemia
1966
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma
1980
The Transfusion of Leukocytes from Donors with Chronic Myelocytic Leukemia to Patients with Leukopenia*
1966
Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo
1990 Science
Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).
1969
Treatment of Acute Myelogenous Leukemia in Children and Adults
1980
Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo.
1989
Chemotherapy of malignant lymphoma with adriamycin.
1973
Persistent Mitosis of Transfused Homologous Leukocytes in Children Receiving Antileukemic Therapy
1963 Science
A Study of Prednisone Therapy in Chronic Lymphocytic Leukemia
1961
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease
1976
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
1978
The role of vincristine in the treatment of childhood acute leukemia
1966
The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia
1965
Combination Chemotherapy in Advanced Hodgkin's Disease
1973
The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia.
1982
Progress and Perspectives in the Chemotherapy of Acute Leukemia
1965